Spreading drug costs over the year may ease financial burden for Medicare cancer patients

A new study examines the potential impact of the Medicare Prescription Payment Plan (M3P)—an opt-in policy implemented in 2025 under the Inflation Reduction Act that allows beneficiaries to spread out-of-pocket (OOP) costs over the calendar…

Continue Reading

News Source: medicalxpress.com